JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on June 12, 2007; DOI: 10.1124/jpet.107.119933


0022-3565/07/3223-1189-1200$20.00
JPET 322:1189-1200, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.107.119933v1
322/3/1189    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fang, Y.
Right arrow Articles by Olah, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fang, Y.
Right arrow Articles by Olah, M. E.

CELLULAR AND MOLECULAR

Cyclic AMP-Dependent, Protein Kinase A-Independent Activation of Extracellular Signal-Regulated Kinase 1/2 Following Adenosine Receptor Stimulation in Human Umbilical Vein Endothelial Cells: Role of Exchange Protein Activated by cAMP 1 (Epac1)

Ying Fang1, and Mark E. Olah

Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, Cincinnati, Ohio (Y.F.); and Department of Pharmaceutical Sciences, College of Pharmacy, Idaho State University, Pocatello, Idaho (M.E.O.)

A critical process in angiogenesis is endothelial cell proliferation, which requires activation of extracellular signal-regulated kinase (ERK)1/2. This study analyzed the pathway responsible for adenosine-induced ERK1/2 phosphorylation in human umbilical vein endothelial cells (HUVEC). Characterization with adenosine receptor (AR) agonists and antagonists and the AR mRNA profile demonstrated that stimulation of the A2BAR can mediate ERK1/2 phosphorylation in HUVEC. The lack of sensitivity of A2BAR-mediated ERK1/2 phosphorylation to 3-[1-[3-(dimethylaminopropyl]-1H-indol-3-yl]-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) and 3-{1-[3-(amidinothio)propyl]-1H-in-dol-3-yl}-3-(1-methyl-1H-indol-3-yl) maleimide (bisindolylmaleimide IX) (Ro31-8220) indicated that protein kinase C stimulation is not required. The response did not involve transactivation of receptors for epidermal growth factor or vascular endothelial growth factor (VEGF). The A2BAR-mediated response required functional G{alpha}s and was mimicked by forskolin and 8-bromoadenosine 3',5'-cyclic monophosphate. However, ERK1/2 phosphorylation induced by A2BAR stimulation and forskolin was insensitive to protein kinase A inhibitors. It was hypothesized that the A2BAR-mediated ERK1/2 activation may involve exchange protein activated by cAMP (Epac), a cAMP-activated guanine nucleotide exchange factor for Rap GTPases. Reverse Transcription-polymerase chain reaction analysis detected Epac1 but not Epac2 in HUVEC. 8-(p-Chlorophenylthio)-2'-O-methyladenosine-3',5'-cyclic monophosphate (8CPT-2Me-cAMP), an Epac activator, stimulated ERK1/2 phosphorylation. Overexpression of Epac1 enhanced A2BAR-mediated and forskolin-induced ERK1/2 phosphorylation, whereas response to VEGF was unaffected. Inhibition of Epac1 expression with small interfering RNA substantially reduced A2BAR-mediated and forskolin-induced ERK1/2 phosphorylation and abolished that by 8CPT-2Me-cAMP. A2BAR stimulation and forskolin activated Rap1. Expression of a dominant-negative Ras protein did not affect either forskolin-induced or A2BAR-mediated ERK1/2 phosphorylation. In summary, Epac1 activation in HUVEC results in ERK1/2 activation, and this protein, at least in part, mediates response to the physiologically relevant event of A2BAR stimulation.


Received January 16, 2007; accepted June 11, 2007.

Address correspondence to: Dr. Mark E. Olah, College of Pharmacy, Box 8334, Idaho State University, Pocatello, ID 83209. E-mail: olahm{at}otc.isu.edu




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. Jin, K. Harada, S. Ohnishi, K. Yamahara, K. Kangawa, and N. Nagaya
Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema
Cardiovasc Res, December 1, 2008; 80(3): 339 - 345.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. K. Huang, S. H. Wettlaufer, J. Chung, and M. Peters-Golden
Prostaglandin E2 Inhibits Specific Lung Fibroblast Functions via Selective Actions of PKA and Epac-1
Am. J. Respir. Cell Mol. Biol., October 1, 2008; 39(4): 482 - 489.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Li, I. B. M. Konings, J. Zhao, L. S. Price, E. de Heer, and P. M. T. Deen
Renal expression of exchange protein directly activated by cAMP (Epac) 1 and 2
Am J Physiol Renal Physiol, August 1, 2008; 295(2): F525 - F533.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M Blandino-Rosano, G Perez-Arana, J M Mellado-Gil, C Segundo, and M Aguilar-Diosdado
Anti-proliferative effect of pro-inflammatory cytokines in cultured {beta} cells is associated with extracellular signal-regulated kinase 1/2 pathway inhibition: protective role of glucagon-like peptide -1
J. Mol. Endocrinol., July 1, 2008; 41(1): 35 - 44.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
S. Sehrawat, X. Cullere, S. Patel, J. Italiano Jr., and T. N. Mayadas
Role of Epac1, an Exchange Factor for Rap GTPases, in Endothelial Microtubule Dynamics and Barrier Function
Mol. Biol. Cell, March 1, 2008; 19(3): 1261 - 1270.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Chrzanowska-Wodnicka, A. E. Kraus, D. Gale, G. C. White II, and J. VanSluys
Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice
Blood, March 1, 2008; 111(5): 2647 - 2656.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.